The FXR agonist 6ECDCA reduces hepatic steatosis and oxidative stress induced by ethanol and low-protein diet in mice

Chemico-Biological Interactions

Volumn 217, Issue , 2014, Pages 19-27

  Livero F A R ^a   Stolf, Aline Maria ^a   Dreifuss, Arturo Alejandro ^a   Bastos Pereira, Amanda Leite ^a   Chicorski, Raphaella ^a   De Oliveira, Liana Gomes ^a   De Souza, Carlos Eduardo Alves ^a   Fabossi, Isabella Aviles ^a   Rabitto, I S ^a   Gremski, Luiza Helena ^a   Henneberg, Raílson ^a   Telles, José Ederaldo Queiroz ^a   Oude Elferink, Ronald P J ^b   Acco, Alexandra ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

6ECDCA; Ethanol; FXR; Liver; Oxidative stress; Steatosis

Indexed keywords

ALCOHOL; AMINOTRANSFERASE; CHOLESTEROL; FAS ANTIGEN; OBETICHOLIC ACID; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL;

ALCOHOL CONSUMPTION; ALCOHOLIC FATTY LIVER; AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; CONTROLLED STUDY; DRUG EFFECT; FAS GENE; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; LIPID PEROXIDATION; LIPID STORAGE; LIVER; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN RESTRICTION; SREBPF1 GENE;

6ECDCA; ETHANOL; FXR; LIVER; OXIDATIVE STRESS; STEATOSIS;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CATALASE; CHENODEOXYCHOLIC ACID; CHOLESTEROL; ETHANOL; FATTY LIVER; GASTROINTESTINAL AGENTS; GLUTATHIONE TRANSFERASE; HISTOCYTOCHEMISTRY; LIVER DISEASES, ALCOHOLIC; MALE; MICE; OXIDATIVE STRESS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SUPEROXIDE DISMUTASE; TRIGLYCERIDES;

EID: 84899841383     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2014.03.014     Document Type: Article

References (44)

1. D.X. Silveira, and F.G. Moreira Panorama atual de drogas e dependências 2006 Editora Atheneu São Paulo 8573797851 493
2. K. Henzel, C. Thorborg, M. Hofmann, G. Zimmer, and U. Leuschner Toxicity of ethanol and acetaldehyde in hepatocytes treated with ursodeoxycholic or tauroursodeoxycholic acid Biochim. Biophys. Acta 1644 2004 37 45
3. D.L. Howarth, M. Passeri, and K.C. Sadler Drinks like a fish: using zebrafish to understand alcoholic liver disease Alcohol. Clin. Exp. Res. 35 2011 826 829
4. M.P. Carrasco, J.M. Jimenez-Lopez, J.L. Segovia, and C. Marco Comparative study of the effects of short- and long-term ethanol treatment and alcohol withdrawal on phospholipid biosynthesis in rat hepatocytes Comp. Biochem. Physiol. B Biochem. Mol. Biol. 131 2002 491 497
5. G. Walldius, and I. Jungner The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy - a review of the evidence J. Intern. Med. 259 2006 493 519
6. W. Zhang, and R.G. Salomon Oxidized phospholipids, isolevuglandins, and atherosclerosis Mol. Nutr. Food Res. 49 2005 1050 1062
7. M. Vidali, S.F. Stewart, and E. Albano Interplay between oxidative stress andimmunity in the progression of alcohol-mediated liver injury Trends Mol. Med. 14 2008 63 71
8. G. Zollner, M. Wagner, and M. Trauner Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity Pharmacol. Ther. 126 2010 228 243
9. M. Meghelli-Bouchenak, J. Belleville, and M. Boquillon Hepatic steatosis and serum very low density lipoproteins during two types of protein malnutrition followed by balanced refeeding Nutrition 5 1989 321 329
10. D.H. Lockwood, J.M. Amatruda, R.T. Moxley, T. Pozefsky, and J.K. Boitnott Effect of oral amino acid supplementation on liver disease after jejunoileal bypass for morbid obesity Am. J. Clin. Nutr. 30 1977 58 63
11. E.A. Carlini, J.C.F. Galduróz, A.R. Noto, et al., II Levantamento domiciliar sobre o uso de drogas psicotrópicas no Brasil: estudo envolvendo as 108 maiores cidades do país - 2005, 2007.
12. E. Christensen, and C. Gluud Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables Gut 37 1995 113 118
13. J.N. Plevris Ursodeoxycholic acid in the treatment of alcoholic liver disease Eur. J. Gastroenterol. Hepatol. 3 1991 653 656
14. S. Zhang, J. Wang, Q. Liu, and D.C. Harnish Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis J. Hepatol. 51 2009 380 388
15. P. Lefebvre, B. Cariou, F. Lien, F. Kuipers, and B. Staels Role of bile acids and bile acid receptors in metabolic regulation Physiol. Rev. 89 2009 147 191
16. J. Wei, D.K. Qiu, and X. Ma Bile acids and insulin resistance. implications for treating nonalcoholic fatty liver disease J. Dig. Dis. 10 2009 85 90
17. S. Fiorucci, G. Rizzo, E. Antonelli, B. Renga, A. Mencarelli, L. Riccardi, A. Morelli, M. Pruzanski, and R. Pellicciari Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis J. Pharmacol. Exp. Ther. 315 2005 58 68
18. J. Folch, M. Lees, and G.A. Stanley A simple method for the isolation and purification of total lipids from animal tissues J. Biol. Chem. 226 1957 497 509
19. H. Aebi Catalase in vitro Methods Enzymol. 105 1984 121 126
20. R. Gao, Z. Yuan, Z. Zhao, and X. Gao Mechanism of pyrogallol autoxidation and determination of superoxide dismutase enzyme activity Bioelectrochem. Bioenerg. 45 1998 41 45
21. W.H. Habig, M.J. Pabst, and W.B. Jakoby Glutathione S-transferases. The first enzymatic step in mercapturic acid formation J. Biol. Chem. 249 1974 7130 7138
22. 2+ in the presence of xylenol orange. Comparison with the TBA assay and an iodometric method Lipids 26 1991 853 856
23. J. Sedlak, and R.H. Lindsay Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent Anal. Biochem. 25 1968 192 205
24. A.S. Driver, P.R.S.K. Kodavanti, and W.R. Mundy Age-related changes in reactive oxygen species production in rat brain homogenates Neurotoxicol. Teratol. 22 2000 175 181
25. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
26. D.E. Kleiner, E.M. Brunt, and N.M. Van et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
27. D.H. Kwon, W. Kang, and Y.S. Nam et al. Dietary protein restriction induces steatohepatitis and alters leptin/signal transducers and activators of transcription 3 signaling in lactating rats J. Nutr. Biochem. 23 2012 791 799
28. M. Nomoto, M. Miyata, and S. Yin et al. Bile acid-induced elevated oxidative stress in the absence of farnesoid X receptor Biol. Pharm. Bull. 32 2009 172 178
29. B. Halliwell Antioxidant defence mechanisms: from the beginning to the end (of the beginning) Free Radic. Res. 31 1999 261 272
30. O.R. Koch, M.E. De Leo, S. Borrello, G. Palombini, and T. Galeotti Ethanol treatment up-regulates the expression of mitochondrial manganese superoxide dismutase in rat liver Biochem. Biophys. Res. Commun. 201 1994 1356 1365
31. O.R. Koch, G. Pani, and S. Borello et al. Oxidative stress and antioxidant defenses in ethanol-induced cell injury Mol. Aspects Med. 25 2004 191 198
32. H. Ishii, I. Kurose, and S. Kato Pathogenesis of alcoholic liver disease with particular emphasis on oxidative stress J. Gastroenterol. Hepatol. 12 1997 272 282
33. D. Wu, and A.I. Cederbaum Oxidative stress and alcoholic liver disease Semin. Liver Dis. 29 2009 141 154
34. J.M. Hassing, A.L. Hupka, S.J. Stohs, and P.C. Yoon Hepatic glutathione levels in D-penicillamine-fed ethanol-dependent rats Res. Commun. Chem. Pathol. Pharmacol. 25 1979 389 394
35. S.M. Bailey, V.B. Patel, T.A. Young, K. Asayama, and C.C. Cunningham Chronic ethanol consumption alters the glutathione/glutathione peroxidase-1 system and protein oxidation status in rat liver Alcohol. Clin. Exp. Res. 25 2001 726 733
36. A.M. Brind, A. Hurlstone, D. Edrisinghe, I. Gilmore, N. Fisher, M. Pirmohamed, and A.A. Fryer The role of polymorphisms of glutathione S-transferases GSTM1, M3, P1, T1 and A1 in susceptibility to alcoholic liver disease Alcohol Alcohol 39 2004 478 483
37. C. Ji, C. Chan, and N. Kaplowitz Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model J. Hepatol. 45 2006 717 724
38. M. You, and D.W. Crabb Molecular mechanisms of alcoholic fatty liver: role of sterol regulatory element-binding proteins Alcohol 34 2002 39 43
39. M. You, M. Fischer, M.A. Deeg, and D.W. Crabb Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP) J. Biol. Chem. 277 2002 29342 29347
40. Z.H. Yang, H. Miyahara, J. Takeo, A. Hatanaka, and M. Katayama Pollock oil supplementation modulates hyperlipidemia and ameliorates hepatic steatosis in mice fed a high-fat diet Lipids Health Dis. 10 2011 189
41. E. Brandon-Warner, L.W. Schrum, C.M. Schmidt, and I.H. McKillop Rodent models of alcoholic liver disease: of mice and men Alcohol 8 2012 715 725
42. C.S. Lieber Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis Alcohol 34 2004 9 19
43. Y. Zhang, L. Yin, J. Anderson, H. Ma, F.J. Gonzalez, T.M. Willson, and P.A. Edwards Identification of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia J. Biol. Chem. 285 2010 3035 3043
44. W. Wu, B. Zhu, X. Peng, M. Zhou, D. Jia, and J. Gu Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease Biochem. Biophys. Res. Commun. 443 2014 68 73